AzTrials
AzTrials

StrabismusRSORNCT07446621

Risk Factors And Surgical Outcomes Of Strabismus Reoperation

A study testing Horizontal Strabismus Reoperation in people with Strabismus and Esotropia, run by Assiut University at 1 site in Egypt.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Horizontal strabismus, commonly known as inward or outward deviation of the eyes, is a frequent eye condition that may require surgical correction. Although the first surgery is often successful, some patients develop residual or recurrent eye misalignment and require a second operation (reoperation). Read more about this study

Who is it for?
Any age
Conditions the study is for
Strabismus, Esotropia, Exotropia
What is being tested?
Horizontal Strabismus Reoperation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
62 participants
Where
1 siteEgypt
Study dates
Mar 2026to Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients diagnosed with horizontal strabismus (esotropia or exotropia).
  • Patients undergoing repeat surgery for correction of residual, recurrent, undercorrected, or overcorrected horizontal strabismus.
  • Availability of sufficient medical records documenting previous strabismus surgery.
  • Ability to attend scheduled postoperative follow-up visits.
  • Written informed consent obtained from the patient or legal guardian.

Who cannot join

  • Combined vertical and horizontal strabismus.
  • Paralytic strabismus.
  • Restrictive strabismus.
  • Strabismus associated with neurological or syndromic conditions.
  • Patients with incomplete or insufficient documentation of previous surgical procedures.
  • Patients unwilling or unable to complete follow-up.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Rehab Safwat Hamza contact

01112603390

Rehabsafwat347@gmail.com

Egypt1 site
  • Assiut university

    Asyut

    Assiut University, 08822080150, vp_grad@aun.edu.eg

Other trials in Egypt

About this study

Official title: Risk Factors And Surgical Outcomes Of Strabismus Reoperation: A Clinical Study

Horizontal strabismus, commonly known as inward or outward deviation of the eyes, is a frequent eye condition that may require surgical correction. Although the first surgery is often successful, some patients develop residual or recurrent eye misalignment and require a second operation (reoperation).

This study aims to identify the clinical and surgical factors that may increase the risk of undercorrection, overcorrection, or recurrence after the first surgery. It also evaluates the outcomes and success rate of repeat surgery in patients with horizontal strabismus.

Read more

Patients undergoing reoperation will receive a complete ophthalmological examination before surgery. The surgical plan will be individualized based on previous surgical history and current eye findings. All procedures will be performed under general anesthesia by the same surgeon. Participants will be followed for three months after surgery to assess eye alignment, movement, and possible complications.

The results of this study may help improve surgical planning and predict which patients are at higher risk of requiring additional surgery in the future.

Read the detailed description

Horizontal strabismus, including esotropia and exotropia, represents the most common form of ocular misalignment requiring surgical intervention. Despite advances in surgical techniques, a proportion of patients experience residual deviation, overcorrection, or recurrence after primary surgery, necessitating reoperation. Reoperation presents unique surgical challenges due to altered anatomy, scar tissue formation, possible muscle slippage, and variability in postoperative healing response.

Reported reoperation rates vary across studies and clinical settings, with multiple patient-related and surgical factors implicated in surgical failure. These factors may include age at primary surgery, magnitude of deviation, amblyopia, number of operated muscles, surgical technique, and time interval between surgeries. However, data regarding predictive risk factors and standardized outcome evaluation in reoperated horizontal strabismus remain limited in the local setting.

This prospective interventional study will be conducted at Assiut University Hospital. It will include patients undergoing repeat surgery for correction of horizontal strabismus. Patients with vertical deviations, paralytic or restrictive strabismus, neurological or syndromic associations, or incomplete previous surgical data will be excluded.

Preoperative assessment will include measurement of visual acuity, cycloplegic refraction, anterior and posterior segment examination, evaluation of ocular motility in nine diagnostic positions of gaze, and measurement of angle of deviation using prism and alternate cover test or Krimsky test when appropriate. Documentation of conjunctival scarring and previous surgical details will be performed.

The surgical approach will be individualized according to preoperative findings and prior operative records. Exploration of previously operated muscles will be performed when clinically indicated. Intraoperative forced duction testing will assess muscle tightness. All surgeries will be conducted under general anesthesia by the same surgeon to reduce inter-operator variability.

Participants will be followed postoperatively at 1 day, 1 week, 1 month, and 3 months. Surgical success will be defined as postoperative alignment within ±10 prism diopters of orthotropia at final follow-up. Secondary outcomes include stability of alignment and postoperative complications such as limitation of ocular motility or conjunctival scarring.

Statistical analysis will evaluate associations between demographic and clinical variables and surgical outcomes using multivariate regression to identify independent risk factors for reoperation outcomes.

The findings of this study aim to improve risk stratification, optimize surgical planning, and enhance long-term outcomes in patients undergoing horizontal strabismus reoperation.

Being tested
Horizontal Strabismus Reoperation
Keywords
Horizontal strabismus, Strabismus reoperation, Recurrent strabismus, Ocular alignment, Prism diopters, Paediatric strabismus surgery, Orthotropia, Ocular motility
Medical subject headings
Strabismus, Esotropia, Exotropia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Horizontal Strabismus ReoperationProcedure or surgery

    Also called Strabismus Reoperation, Repeat Strabismus Surgery, Horizontal Rectus Muscle Reoperation

    Horizontal strabismus reoperation is performed to correct residual or recurrent esotropia or exotropia following previous strabismus surgery. The surgical plan is individualized based on preoperative assessment and prior operative records. Previously operated muscles are explored when limited ocular motility, scarring, or suspected muscle slippage is present. In other cases, surgery may be performed on unoperated horizontal rectus muscles when appropriate. Intraoperative forced duction testing is conducted to assess muscle tightness, and scar tissue is released when indicated. All procedures are performed under general anesthesia by the same surgeon. Postoperative alignment and ocular motility are evaluated during follow-up visits.

Study groups in NCT07446621
Study groupRoleWhat they receive
Horizontal Strabismus ReoperationExperimentalAll enrolled participants undergo repeat surgery for correction of horizontal strabismus (esotropia or exotropia). The surgical approach is individualized based on preoperative clinical evaluation and prior operative records. Exploration of previously operated muscles is performed when indicated, particularly in cases of limited ocular motility or suspected scarring. Otherwise, surgery is performed on unoperated horizontal rectus muscles when appropriate. Intraoperative forced duction testing is conducted to assess muscle tightness, and scar tissue release is performed if necessary. All procedures are performed under general anesthesia by the same surgeon. Participants are followed postoperatively to evaluate alignment, ocular motility, and surgical outcomes.
Receives: Procedure: Horizontal Strabismus Reoperation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate Of Surgical Success After Horizontal Strabismus Reoperation

    Percentage of participants achieving postoperative ocular alignment within ±10 prism diopters of orthotropia measured using the Prism and Alternate Cover Test at distance fixation.

    Measured: 3 months postoperative

Secondary outcomes (4)
  1. Preoperative Angle Of Deviation

    Angle of ocular deviation measured in prism diopters using the Prism and Alternate Cover Test at distance fixation before surgery.

    Measured: Baseline (preoperative)

  2. Age At Primary Strabismus Surgery

    Age of the participant at the time of initial strabismus surgery obtained from medical records.

    Measured: Baseline

  3. Presence Of Amblyopia

    Presence of amblyopia determined by best corrected visual acuity assessment during preoperative evaluation.

    Measured: Baseline

  4. Number Of Extraocular Muscles Operated During Reoperation

    Number of horizontal rectus muscles surgically operated during the reoperation procedure.

    Measured: Intraoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Mar 2026
  2. Study startMar 2026 (estimated)
  3. Primary completionMay 2027 (estimated)
  4. Study completionJul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
This is a prospective single-group interventional study in which all enrolled participants undergo horizontal strabismus reoperation. Outcomes are evaluated postoperatively, and clinical and surgical variables are analyzed to identify risk factors associated with surgical success or recurrence.
Masking
None (open label)
Enrolment
62 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07446621
Sponsor's protocol ID
AUH-STRAB-REOP-2026
Acronym
RSOR
Status last verified
Mar 2026
First submitted
24 Feb 2026
Last updated
9 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rajavi Z, Gozin M, Sabbaghi H, Behradfar N, Kheiri B, Faghihi M. Reoperation in Horizontal Strabismus and its Related Risk Factors. Med Hypothesis Discov Innov Ophthalmol. 2018 Summer;7(2):73-82.

    PubMed 30250856
  • Heo H, Lambert SR. Effect of age on reoperation rate in children undergoing exotropia surgery. Acta Ophthalmol. 2021 Nov;99(7):e1206-e1211. doi: 10.1111/aos.14771. Epub 2021 Feb 2.

    PubMed 33529446
  • Yetkin AA. Factors Affecting Surgical Success Rates in Pediatric Horizontal Strabismus Surgery. Cureus. 2024 Nov 29;16(11):e74758. doi: 10.7759/cureus.74758. eCollection 2024 Nov.

    PubMed 39734963
  • Akbari MR. Preoperative factors associated with multiple strabismus surgeries: a large retrospective database study. Optom Vis Sci. 2026;103(1):45-52.

  • Olitsky SE, Coats DK. Complications of Strabismus Surgery. Middle East Afr J Ophthalmol. 2015 Jul-Sep;22(3):271-8. doi: 10.4103/0974-9233.159692.

    PubMed 26180463
  • Niu R, Lv P, Hao R, Zhang W. Comprehensive analysis of strabismus reoperations: clinical insights and progression factors. BMC Ophthalmol. 2024 Oct 11;24(1):446. doi: 10.1186/s12886-024-03712-2.

    PubMed 39394059
  • Samplaski MK. Editorial Commentary. Urol Pract. 2019 Jan;6(1):44. doi: 10.1097/01.UPJ.0000552857.40544.a1. Epub 2018 Dec 27. No abstract available.

    PubMed 37312345

Questions about this trial

What is this clinical trial studying?

A study testing Horizontal Strabismus Reoperation in people with Strabismus and Esotropia, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rehab Safwat Hamza (01112603390, Rehabsafwat347@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate Of Surgical Success After Horizontal Strabismus Reoperation (time frame: 3 months postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07446621, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in